Clara Forcada Barreda
Research Subjects
Clara Forcada Barreda has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Elena Prisciandaro
Department of Thoracic Surgery, University Hospitals of Brussels, 1070 Brussels, Belgium
3 shared publications - Isabelle Opitz
Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
3 shared publications - Jean-Marc Baste
Department of General and Cardiothoracic Surgery, University Hospital Rouen, 76031 Rouen, France
3 shared publications - Laurens Joseph Ceulemans
Department of Thoracic Surgery, University Hospitals Leuven, Belgium
3 shared publications - Lin Huang
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications - Lorenzo Spaggiari
Department of Oncology and Hemato-oncology, University of Milan, 20122 Milan, Italy
3 shared publications
Latest Publications
- Open Access
- 25 May 2026
- Published by Elsevier in Lung Cancer
- Vol. 217, 109410
European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy
- 25 May 2026
- Published by Elsevier in Lung Cancer
- Vol. 217, 109410
Open AccessEuropean experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy
- Open Access
Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis
Objectives: Pulmonary metastasectomy is not a standardised procedure, with no consensus regarding the optimal extent of lung resection. This international multicentre study aimed at comparing short and long-term outcomes of anatomical versus non-anatomical pulmonary metastasectomy. Methods: Retrospective database including 1647 patients aged ≥18 years, who underwent curative intent pulmonary metastasectomy between January 2010 and December 2018 at 15 European centres. Patients who underwent pneumonectomy, previous metastasectomies, and/or suffered from extrapulmonary recurrence at the time of lung surgery were excluded. Primary endpoint was overall survival. Secondary endpoints were recurrence-free survival and 30-day morbidity. Differences between the two groups were analysed using 3:1 matching. Results: In the matched cohort, 324 patients underwent anatomical resection, and 830 patients underwent non-anatomical resection. Five-year overall survival was 62.0%. Averaged over the entire follow-up, there was no significant difference in overall survival between the two groups (HR = 1.122, 95% CI = 0.909–1.385, p = 0.283). In the early period following pulmonary metastasectomy, anatomical resections were associated with worse overall survival (HR = 1.549, 95% CI = 1.135–2.114, p = 0.006). The difference in any-site recurrence-free survival between the two groups was not significant (HR = 0.832, 95% CI = 0.690–1.002, p = 0.053). Locoregional recurrence-free survival was significantly longer after anatomical resection (HR = 0.651, 95% CI = 0.520–0.817, p < 0.001). Thirty-day morbidity was significantly higher after anatomical resection (22.2% versus 13.7% for non-anatomical resections, p = 0.001). Conclusions: In a highly selected cohort, non-anatomical resection showed comparable survival and lower morbidity compared to anatomical resections, supporting the surgical strategy of favouring limited resections whenever technically and oncologically feasible. Anatomical resections remain a valid option in selected cases with acceptable outcomes.
Open AccessAnatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis
Objectives: Pulmonary metastasectomy is not a standardised procedure, with no consensus regarding the optimal extent of lung resection. This international multicentre study aimed at comparing short and long-term outcomes of anatomical versus non-anatomical pulmonary metastasectomy. Methods: Retrospective database including 1647 patients aged ≥18 years, who underwent curative intent pulmonary metastasectomy between January 2010 and December 2018 at 15 European centres. Patients who underwent pneumonectomy, previous metastasectomies, and/or suffered from extrapulmonary recurrence at the time of lung surgery were excluded. Primary endpoint was overall survival. Secondary endpoints were recurrence-free survival and 30-day morbidity. Differences between the two groups were analysed using 3:1 matching. Results: In the matched cohort, 324 patients underwent anatomical resection, and 830 patients underwent non-anatomical resection. Five-year overall survival was 62.0%. Averaged over the entire follow-up, there was no significant difference in overall survival between the two groups (HR = 1.122, 95% CI = 0.909–1.385, p = 0.283). In the early period following pulmonary metastasectomy, anatomical resections were associated with worse overall survival (HR = 1.549, 95% CI = 1.135–2.114, p = 0.006). The difference in any-site recurrence-free survival between the two groups was not significant (HR = 0.832, 95% CI = 0.690–1.002, p = 0.053). Locoregional recurrence-free survival was significantly longer after anatomical resection (HR = 0.651, 95% CI = 0.520–0.817, p < 0.001). Thirty-day morbidity was significantly higher after anatomical resection (22.2% versus 13.7% for non-anatomical resections, p = 0.001). Conclusions: In a highly selected cohort, non-anatomical resection showed comparable survival and lower morbidity compared to anatomical resections, supporting the surgical strategy of favouring limited resections whenever technically and oncologically feasible. Anatomical resections remain a valid option in selected cases with acceptable outcomes.
- Open Access
- 1 December 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (12)
Preoperative Factors Associated with Surgical Complexity and Postoperative Outcomes in Patients Undergoing Robotic Anatomical Segmentectomy
Objectives: Anatomical segmentectomy is increasingly used for early-stage lung cancer due to its parenchymal-sparing benefits. However, it remains technically challenging, and procedural complexity is often inconsistently defined. Robotic-assisted surgery, offering enhanced dexterity and visualization, has become more widespread but still requires high technical expertise. This study aimed to identify preoperative factors associated with procedural complexity and evaluate its impact on postoperative outcomes. Methods: This single-centre cohort study included 160 consecutive patients who underwent robotic segmentectomy by 2 expert surgeons between November 2018 and August 2025. Complex procedures were defined as those with operative time >125 min (75th percentile), conversion to another surgical approach, or changes in the planned resection due to intraoperative technical challenges. Logistic regression was used to identify preoperative variables associated with complexity. Postoperative outcomes were compared between complex and non-complex cases. Results: Thirty-seven segmentectomies (23.1%) were classified as complex. Predictors of complexity included age (odds ratio [OR] = 1.042, P = .063), transverse pleural diameter (OR = 0.716, P = .089), and number of staple planes (OR = 1.644, P = .058), while the presence of emphysema (OR = 0.428, P = .076) appeared to be protective. Mortality, overall morbidity, prolonged air leak, and readmission rates were similar between groups. However, complex cases had significantly higher rates of major morbidity (13.5% vs 1.6%, P = .008), reintervention (10.8% vs 0.8%, P = .010), and longer hospital stays (median 3 vs 2 days, P = .004). Conclusions: This exploratory analysis identified preoperative factors associated with procedural complexity in robotic segmentectomy. These findings may help improve patient selection, surgical planning, resource allocation, and structured training.
- 1 December 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (12)
Open AccessPreoperative Factors Associated with Surgical Complexity and Postoperative Outcomes in Patients Undergoing Robotic Anatomical Segmentectomy
Objectives: Anatomical segmentectomy is increasingly used for early-stage lung cancer due to its parenchymal-sparing benefits. However, it remains technically challenging, and procedural complexity is often inconsistently defined. Robotic-assisted surgery, offering enhanced dexterity and visualization, has become more widespread but still requires high technical expertise. This study aimed to identify preoperative factors associated with procedural complexity and evaluate its impact on postoperative outcomes. Methods: This single-centre cohort study included 160 consecutive patients who underwent robotic segmentectomy by 2 expert surgeons between November 2018 and August 2025. Complex procedures were defined as those with operative time >125 min (75th percentile), conversion to another surgical approach, or changes in the planned resection due to intraoperative technical challenges. Logistic regression was used to identify preoperative variables associated with complexity. Postoperative outcomes were compared between complex and non-complex cases. Results: Thirty-seven segmentectomies (23.1%) were classified as complex. Predictors of complexity included age (odds ratio [OR] = 1.042, P = .063), transverse pleural diameter (OR = 0.716, P = .089), and number of staple planes (OR = 1.644, P = .058), while the presence of emphysema (OR = 0.428, P = .076) appeared to be protective. Mortality, overall morbidity, prolonged air leak, and readmission rates were similar between groups. However, complex cases had significantly higher rates of major morbidity (13.5% vs 1.6%, P = .008), reintervention (10.8% vs 0.8%, P = .010), and longer hospital stays (median 3 vs 2 days, P = .004). Conclusions: This exploratory analysis identified preoperative factors associated with procedural complexity in robotic segmentectomy. These findings may help improve patient selection, surgical planning, resource allocation, and structured training.
- 24 October 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 66 (5)
European multicentre study evaluating the prognosis of peripheral early-stage lung adenocarcinoma patients operated on by segmentectomy or lobectomy
OBJECTIVES: To analyse impact of segmentectomy on oncological outcomes of different peripheral early-stage lung adenocarcinoma patterns. METHODS: Retrospective multicentre study including patients who underwent either lobectomy or segmentectomy in 6 European centres from 2015 to 2021, for ≤2 cm pathological peripheral lung adenocarcinoma. Overall and disease-free survivals were assessed by cox-regression and lung cancer-specific survival by competing regression analyses to adjust for patient- and tumour-related factors both in the entire dataset and the in aggressive adenocarcinoma patterns dataset. RESULTS: Lobectomy and segmentectomy were performed in 481 (71%) and 193 (29%) patients, respectively. Propensity score matching was performed (n = 191). One hundred and 8 patients had a least an aggressive pattern. Five-year disease-free, overall and lung cancer-specific survivals were similar between patients who underwent lobectomy or segmentectomy in both entire and aggressive pattern datasets. In patients with aggressive pattern, 5-year disease-free (lobectomy 87.3%; segmentectomy 86.6%, P = 0.62), overall (lobectomy 86.4%; segmentectomy 95.6%, P = 0.61) and lung cancer-specific (lobectomy 100%; segmentectomy 95.6%, P = 0.13) survivals did not differ. Segmentectomy was not an independent risk factor for disease-free survival, neither for overall survival nor for lung cancer-specific survival in any of the 2 datasets. In patients with aggressive pattern, loco-regional recurrence (linearized risks: lobectomy 8.21; segmentectomy 11.3) was higher in patients who underwent segmentectomy. CONCLUSIONS: Resection should not be extended (to lobectomy) on patients who underwent segmentectomy for pathologically proven early-stage adenocarcinoma with aggressive patterns.
- 24 October 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 66 (5)
European multicentre study evaluating the prognosis of peripheral early-stage lung adenocarcinoma patients operated on by segmentectomy or lobectomy
OBJECTIVES: To analyse impact of segmentectomy on oncological outcomes of different peripheral early-stage lung adenocarcinoma patterns. METHODS: Retrospective multicentre study including patients who underwent either lobectomy or segmentectomy in 6 European centres from 2015 to 2021, for ≤2 cm pathological peripheral lung adenocarcinoma. Overall and disease-free survivals were assessed by cox-regression and lung cancer-specific survival by competing regression analyses to adjust for patient- and tumour-related factors both in the entire dataset and the in aggressive adenocarcinoma patterns dataset. RESULTS: Lobectomy and segmentectomy were performed in 481 (71%) and 193 (29%) patients, respectively. Propensity score matching was performed (n = 191). One hundred and 8 patients had a least an aggressive pattern. Five-year disease-free, overall and lung cancer-specific survivals were similar between patients who underwent lobectomy or segmentectomy in both entire and aggressive pattern datasets. In patients with aggressive pattern, 5-year disease-free (lobectomy 87.3%; segmentectomy 86.6%, P = 0.62), overall (lobectomy 86.4%; segmentectomy 95.6%, P = 0.61) and lung cancer-specific (lobectomy 100%; segmentectomy 95.6%, P = 0.13) survivals did not differ. Segmentectomy was not an independent risk factor for disease-free survival, neither for overall survival nor for lung cancer-specific survival in any of the 2 datasets. In patients with aggressive pattern, loco-regional recurrence (linearized risks: lobectomy 8.21; segmentectomy 11.3) was higher in patients who underwent segmentectomy. CONCLUSIONS: Resection should not be extended (to lobectomy) on patients who underwent segmentectomy for pathologically proven early-stage adenocarcinoma with aggressive patterns.
- 29 March 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 65 (4)
Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective
OBJECTIVES: To assess the current practice of pulmonary metastasectomy at 15 European Centres. Short- and long-term outcomes were analysed. METHODS: Retrospective analysis on patients ≥18 years who underwent curative-intent pulmonary metastasectomy (January 2010 to December 2018). Data were collected on a purpose-built database (REDCap). Exclusion criteria were: previous lung/extrapulmonary metastasectomy, pneumonectomy, non-curative intent and evidence of extrapulmonary recurrence at the time of lung surgery. RESULTS: A total of 1647 patients [mean age 59.5 (standard deviation; SD = 13.1) years; 56.8% males] were included. The most common primary tumour was colorectal adenocarcinoma. The mean disease-free interval was 3.4 (SD = 3.9) years. Relevant comorbidities were observed in 53.8% patients, with a higher prevalence of metabolic disorders (32.3%). Video-assisted thoracic surgery was the chosen approach in 54.9% cases. Wedge resections were the most common operation (67.1%). Lymph node dissection was carried out in 41.4% cases. The median number of resected lesions was 1 (interquartile range 25–75% = 1–2), ranging from 1 to 57. The mean size of the metastases was 18.2 (SD = 14.1) mm, with a mean negative resection margin of 8.9 (SD = 9.4) mm. A R0 resection of all lung metastases was achieved in 95.7% cases. Thirty-day postoperative morbidity was 14.5%, with the most frequent complication being respiratory failure (5.6%). Thirty-day mortality was 0.4%. Five-year overall survival and recurrence-free survival were 62.0% and 29.6%, respectively. CONCLUSIONS: Pulmonary metastasectomy is a low-risk procedure that provides satisfactory oncological outcomes and patient survival. Further research should aim at clarifying the many controversial aspects of its daily clinical practice.
- 29 March 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 65 (4)
Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective
OBJECTIVES: To assess the current practice of pulmonary metastasectomy at 15 European Centres. Short- and long-term outcomes were analysed. METHODS: Retrospective analysis on patients ≥18 years who underwent curative-intent pulmonary metastasectomy (January 2010 to December 2018). Data were collected on a purpose-built database (REDCap). Exclusion criteria were: previous lung/extrapulmonary metastasectomy, pneumonectomy, non-curative intent and evidence of extrapulmonary recurrence at the time of lung surgery. RESULTS: A total of 1647 patients [mean age 59.5 (standard deviation; SD = 13.1) years; 56.8% males] were included. The most common primary tumour was colorectal adenocarcinoma. The mean disease-free interval was 3.4 (SD = 3.9) years. Relevant comorbidities were observed in 53.8% patients, with a higher prevalence of metabolic disorders (32.3%). Video-assisted thoracic surgery was the chosen approach in 54.9% cases. Wedge resections were the most common operation (67.1%). Lymph node dissection was carried out in 41.4% cases. The median number of resected lesions was 1 (interquartile range 25–75% = 1–2), ranging from 1 to 57. The mean size of the metastases was 18.2 (SD = 14.1) mm, with a mean negative resection margin of 8.9 (SD = 9.4) mm. A R0 resection of all lung metastases was achieved in 95.7% cases. Thirty-day postoperative morbidity was 14.5%, with the most frequent complication being respiratory failure (5.6%). Thirty-day mortality was 0.4%. Five-year overall survival and recurrence-free survival were 62.0% and 29.6%, respectively. CONCLUSIONS: Pulmonary metastasectomy is a low-risk procedure that provides satisfactory oncological outcomes and patient survival. Further research should aim at clarifying the many controversial aspects of its daily clinical practice.
- 26 July 2022
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 101 (1) , 51-54
Usefulness of near-infrared fluorescence for identifying the segmental bronchus in minimally invasive segmentectomy
- 26 July 2022
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 101 (1) , 51-54
Usefulness of near-infrared fluorescence for identifying the segmental bronchus in minimally invasive segmentectomy